Blue Earth Diagnostics

POSLUMA

Manufacturer:

Blue Earth Diagnostics

Posluma HCPCS:

A9608

HCPCS Code Descriptor:

Flotufolastat f 18, diagnostic, 1 millicurie

Category:

A Code

Posluma NDCs:

69932-0002-01

Primary Type:

Imaging/Radiopharmaceutical

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

69932-0002-01

About Posluma:

POSLUMA is an Imaging/Radiopharmaceutical drug manufactured by Blue Earth Diagnostics and administered via the Intravenous route of administration. The A Code: A9608 is aligned to the drug POSLUMA.

Posluma is an injection used to diagnose prostate cancer. Posluma is an imaging agent used in PET scans. It is designed to specifically prostate cancer cells, making them more visible on scans. Doctors use this medication to locate cancer cells, and increases the chances of accurate diagnoses.

ACCESS PRICING AND MORE BY REGISTERING

A9608 Added Date:

January 1, 2024

A9608 Effective Date:

January 1, 2024

A9608 Termination Date:

HCPCS Active

Posluma billing and coding information can be found through Blue Earth Diagnostics at the link below:
Our team did not identify a source for Posluma patient assistance information. Please reach out to our team if you feel that this is a mistake.
POSLUMA prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for POSLUMA. Please check back in a few weeks.